These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36815649)

  • 1. WITHDRAWN: LncRNA MCM3AP-AS1 Enhances Cell Invasion, Migration and Tumor Formation in Non-small Cell Lung Cancer Cells by Epigenetic Inhibition of miR-34a.
    Zhang H; Cao Y; Tang J; Wang R
    Curr Pharm Biotechnol; 2023 Feb; ():. PubMed ID: 36815649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.
    Ganna I; Anna S
    Curr Cardiol Rev; 2022 May; ():. PubMed ID: 35570515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.
    Khan A; Wei DQ
    Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Recent Advances of Nanotechnology in the Treatment of Skin Cancer.
    Kanugo A
    Curr Pharm Biotechnol; 2022 Apr; ():. PubMed ID: 35379144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Therapeutic Targeted Approaches for Covid-19 Treatment.
    Rajawat J; Misra G; Anvikar AK; Era B
    Curr Pharm Biotechnol; 2022 Mar; ():. PubMed ID: 35249480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Main Diagnostic Methods for COVID-19: Integrative Review.
    de Campos ASM; de Souza GAF; de Jesus RA; Zardeto G; Donadel G; Dalmagro M; de Almeida Canoff JR; Hoscheid J; Alberton O; Boleta-Ceranto DCF; Gonçalves DD; Botelho Lourenço EL; Cogo J
    Curr Pharm Des; 2022 May; ():. PubMed ID: 35619252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Stromal Cell-Derived Factor 1 Secreted by Cancer- Associated Fibroblasts Promotes lncRNA Xist through CXCR4 and Facilitates Invasion and Metastasis of Non-Small Cell Lung Cancer.
    Wang L; Chen W; Li X; Zhao H
    Curr Cancer Drug Targets; 2022 Apr; ():. PubMed ID: 35392783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Conjugation of Ruthenium Drugs to Nanocellulose using Boronic Ester.
    Lu M; Khine YY; Shen Y; Stenzel MH
    Curr Drug Deliv; 2023 Feb; ():. PubMed ID: 36797605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: LppDB - A Comprehensive Database for Lipopeptide based Drugs: Exploring Potential Drug Discovery Aspects.
    Yadav M; Eswari JS
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37038708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Smart Trends: Liposome-Based Nanocarriers for Cancer Treatment and its Applications.
    Khatoon R; Huda S; Alam MA
    Pharm Nanotechnol; 2022 Feb; ():. PubMed ID: 35142276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Moderna’s COVID 19 Patent Under the Magnifying Glass.
    Storz U
    Recent Pat Biotechnol; 2022 Jun; ():. PubMed ID: 35713124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Recent Advances and Reports on Encapsulation in the Food Matrix: A Review.
    Potdar SB; Saudagar P; Potoroko I; Bagale U; Sonawane S; Sonawane SH
    Curr Pharm Biotechnol; 2022 May; ():. PubMed ID: 35570555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN: Comparing Nucleated Red Blood Cells in Neonates with and without Retinopathy.
    Boskabadi H; Pourbadakhshan N; Pishghadam E; Zakerihamidi M
    Curr Pediatr Rev; 2021 Sep; ():. PubMed ID: 34503429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: In silico and Experimental Analysis of miR-125b-5 and miR-485-5p Expression in Serum of Patients with Breast Cancer.
    Bahmanpour Z; Sheervalilou R; Khaniani MS; Poursheikhani A; Montazeri V; Tahmasebivand M; Derakhshan SM
    Microrna; 2022 May; ():. PubMed ID: 35616663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Scrutinizing the Role of Genetically Modified Herbs (GMHs) in the Treatment of Various Diseases.
    Sindhu RK; Verma R; Salgotra T; Madaan P; Chandel P; Batiha GE; Cavalu S
    Recent Pat Biotechnol; 2022 May; ():. PubMed ID: 35549856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN: Salmonella typhi: A Review of Antibiogram Journey in Developing Countries.
    Singhal L; Sandhu D; Kour I; Gupta V
    Infect Disord Drug Targets; 2022 Jun; ():. PubMed ID: 35692133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Nucleic Acid-Based Vaccines Platform Against Covid-19 Pandemic.
    Baghban R; Mahmoodi S
    Curr Mol Med; 2022 Jan; ():. PubMed ID: 34994327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Imaging Features of Primary Non-Hodgkin’s Lymphoma of Long Bones.
    Han ZW; Wu Y; Han SM; Cao L; Liu C; Yang C; Yang HH; Wu WJ; Gao BL; Yu BH
    Curr Med Imaging; 2023 Feb; ():. PubMed ID: 36733202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Ivabradine for Uncontrolled Sinus Tachycardia in Thyrotoxic Cardiomyopathy – Case Report.
    Frenkel A; Bichovsky Y; Arotsker N; Besser L; Joshua BZ; Fraenkel M; Zahger D; Klein M
    Endocr Metab Immune Disord Drug Targets; 2021 Sep; ():. PubMed ID: 34544353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Impact of Racial Differences on the Epidemiology and Clinical Outcomes of Atrial Fibrillation.
    Quah JX; Dharmaprani D; Tiver K; McGavigan AD; Ganesan AN
    Curr Cardiol Rev; 2021 Dec; ():. PubMed ID: 34886777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.